Syneos Health and Medable have announced a partnership to deliver decentralized capabilities to Syneos Health with the aim of increasing clinical trial diversity, while also aiming to improving patient access and experiences.
Syneos Health will gain access to Medable’s digital platform as well as deliver a decentralized digital solution to Syneos Health customers tailored to the specific attributes and requirements for conducting non-interventional research.
Medable will also now be part of the Syneos Health Dynamic Assembly network, an open ecosystem of data and technology collaborators committed to delivering solutions designed to strategically address the nuances of each customer engagement.
For more information, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.